Calliditas Therapeutics AB American Depositary Shares
CALT
CALT was delisted on the 20th of September, 2024.
14 hedge funds and large institutions have $32.7M invested in Calliditas Therapeutics AB American Depositary Shares in 2021 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 7 closing their positions.
50% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 2
0% more funds holding
Funds holding: 14 → 14 (0)
0% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 7
49% less capital invested
Capital invested by funds: $64.5M → $32.7M (-$31.8M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
IIM
Ironwood Investment Management
Boston,
Massachusetts
|
+$455K |
| 2 |
Jane Street
New York
|
+$206K |
| 3 |
NFG
Next Financial Group
Houston,
Texas
|
+$128K |
| 4 |
ASN
Advisory Services Network
Atlanta,
Georgia
|
+$96.4K |
| 5 |
ECM
Endurant Capital Management
San Mateo,
California
|
+$59.2K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HA
HHLR Advisors
Grand Cayman,
Cayman Islands
|
-$26.1M |
| 2 |
VC
Vivo Capital
Palo Alto,
California
|
-$7.12M |
| 3 |
OMC
Old Mission Capital
Chicago,
Illinois
|
-$500K |
| 4 |
Millennium Management
New York
|
-$430K |
| 5 |
Tudor Investment Corp
Stamford,
Connecticut
|
-$380K |
CALT Hedge Fund Activity: Q2 2021 in Review
14 of the 5,767 institutional investors tracked by Wall St. Rank reported a position in Calliditas Therapeutics AB American Depositary Shares (CALT) for Q2 2021, worth a combined $32.7M — down 49% from $64.5M a quarter earlier.
Fund positioning in CALT was balanced in Q2 2021: 7 funds opened new positions, 7 closed out, 3 added to existing stakes and 2 trimmed.
The largest buyer was Ironwood Investment Management, opening a new position worth an estimated $455K. The largest seller was HHLR Advisors, exiting entirely with an estimated $26.1M sold.
- 14 institutional investors held Calliditas Therapeutics AB American Depositary Shares (CALT) as of Q2 2021, unchanged from Q1 2021.
- Funds reported $32.7M of Calliditas Therapeutics AB American Depositary Shares stock for Q2 2021, down 49% quarter-over-quarter.
- 7 funds opened new Calliditas Therapeutics AB American Depositary Shares positions in Q2 2021 and 7 closed out, a net change of 0 holders.
- The largest Calliditas Therapeutics AB American Depositary Shares buyer in Q2 2021 was Ironwood Investment Management, an estimated $455K added.
- The largest Calliditas Therapeutics AB American Depositary Shares seller in Q2 2021 was HHLR Advisors, an estimated $26.1M sold.
Based on aggregated 13F filings for Q2 2021.